Li LF - Search Results

1

Capecitabine combined with weekly docetaxel in Chinese patients > 65 years with anthracycline-resistant metastatic breast cancer.

Wang HQ, Qian ZZ, Liu XM, Zhang HL, Li LF, Qiu LH, Hou Y, Zhou SY, Hao XS, Xie CH. Wang HQ, et al. Among authors: li lf. Chin Med J (Engl). 2010 Nov;123(22):3212-6. Chin Med J (Engl). 2010. PMID: 21163117 Clinical Trial.

2

[DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].

Liu XM, Wang HQ, Zhang HL, Qiu LH, Li W, Li LF, Cui XZ, Liu PF, Hao XS. Liu XM, et al. Among authors: li w, li lf. Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):779-82. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19173813 Clinical Trial. Chinese.

3

[Nimotuzumab in combination with chemotherapy in patients with advanced non-small cell lung cancer].

Li LF, Wang HQ, Liu XM, Zhang HL, Qiu LH, Qian ZZ, Li W. Li LF, et al. Among authors: li w. Zhonghua Zhong Liu Za Zhi. 2011 Aug;33(8):626-8. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22325226 Chinese.

4

[Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].

Hou Y, Wang HQ, Fu K, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Among authors: li w, li lf. Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):911-5. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340100 Chinese.

5

[Efficacy and survival status of retuximab-NCE regimen treatment in patients with relapsed or refractory B cell non-Hodgkin's lymphoma].

Hou Y, Wang HQ, Fu K, Liu XM, Zhang HL, Qian ZZ, Qiu LH, Li W, Zhou SY, Li LF, Hao XS. Hou Y, et al. Among authors: li w, li lf. Zhonghua Zhong Liu Za Zhi. 2012 Apr;34(4):306-10. doi: 10.3760/cma.j.issn.0253-3766.2012.04.015. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22781046 Chinese.

6

Epirubicin inhibits soluble CD25 secretion by Treg cells isolated from diffuse large B-cell lymphoma patients.

Li LF, Wang HQ, Liu XM, Ren XB. Li LF, et al. Asian Pac J Cancer Prev. 2013;14(3):1721-4. doi: 10.7314/apjcp.2013.14.3.1721. Asian Pac J Cancer Prev. 2013. PMID: 23679263 Free article.

7

Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells.

Dong L, Lv H, Li W, Song Z, Li L, Zhou S, Qiu L, Qian Z, Liu X, Feng L, Meng B, Fu K, Wang X, Pan-Hammarström Q, Wang P, Wang X, Zhang H. Dong L, et al. Oncotarget. 2016 May 31;7(22):33350-62. doi: 10.18632/oncotarget.9061. Oncotarget. 2016. PMID: 27147575 Free PMC article.

8

miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma.

Fan Q, Meng X, Liang H, Zhang H, Liu X, Li L, Li W, Sun W, Zhang H, Zen K, Zhang CY, Zhou Z, Chen X, Ba Y. Fan Q, et al. Protein Cell. 2016 Dec;7(12):899-912. doi: 10.1007/s13238-016-0316-z. Epub 2016 Nov 4. Protein Cell. 2016. PMID: 27815824 Free PMC article.

9

Upconverting and persistent luminescent nanocarriers for accurately imaging-guided photothermal therapy.

Zhao P, Ji W, Zhou S, Qiu L, Li L, Qian Z, Liu X, Zhang H, Cao X. Zhao P, et al. Mater Sci Eng C Mater Biol Appl. 2017 Oct 1;79:191-198. doi: 10.1016/j.msec.2017.05.046. Epub 2017 May 10. Mater Sci Eng C Mater Biol Appl. 2017. PMID: 28629007

10

Necroptosis as a potential therapeutic target in multiple organ dysfunction syndrome.

Cui YL, Qiu LH, Zhou SY, Li LF, Qian ZZ, Liu XM, Zhang HL, Ren XB, Wang YQ. Cui YL, et al. Among authors: li lf. Oncotarget. 2017 May 29;8(34):56980-56990. doi: 10.18632/oncotarget.18252. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915647 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

795 results

Search Page

Filters